S
Shigeji Sato
Researcher at Sumitomo Chemical
Publications - 49
Citations - 883
Shigeji Sato is an academic researcher from Sumitomo Chemical. The author has contributed to research in topics: Gelatin & Active ingredient. The author has an hindex of 15, co-authored 49 publications receiving 881 citations.
Papers
More filters
Patent
Sustained pulsewise release pharmaceutical preparation
Keiji Sumitomo Pharmaceuticals Co. Ltd. Fujioka,Shigeji Sato,Yoshihiro Takada,Yoshio Sasaki,Nobuhiko Sumitomo Pharmaceuticals Co. Ltd. Tamura +4 more
TL;DR: In this paper, the authors proposed a sustained pulse-wise release pharmaceutical preparation, which comprises drug-containing polymeric material layers (layers A) and polymica material layers containing the drug in question only in a small amount or free of the drug (layer B) disposed alternatingly, with the whole surface extending in the direction perpendicular to the layer plane being coated with polymeric materials which is insoluble in water or scarcely soluble in water.
Patent
Solid preparation administering instrument.
TL;DR: An equipment for administering solid or semisolid preparations under the skin, which comprises a solid needle (1) member with an acute tip end (1a), and a cylindrical member (3) slidably mounted on the needle member, is described in this paper.
Patent
Prolonged sustained-release preparations
TL;DR: In this article, a sustained-release preparation in the form of a needle-like or bar-like shape, which comprises an active ingredient and a pharmaceutically acceptable biodegradable carrier (e.g., proteins, polysaccharides and synthetic high molecular compounds, preferably collagen, atelocollagen, gelatin, and a mixture thereof) is presented.
Journal ArticleDOI
Novel delivery system for proteins using collagen as a carrier material : The minipellet
TL;DR: The minipellet is applicable to various kinds of biologically active peptides and proteins and expected to facilitate their potential therapeutic use and is easily administered in the same way as conventional injections.
Patent
Sustained-release injection
TL;DR: In this article, a sustained-release injection is proposed, which comprises a suspension of a powder comprising an active ingredient and a pharmaceutically acceptable biodegradable carrier (e.g. proteins, polysaccharides and synthetic high molecular compounds) in a viscous solvent for injection.